zithromax and Remission--Spontaneous

Topics: Anti-Bacterial Agents; Azithromycin; Doxycycline; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Remission, Spontaneous; Time Factors; Treatment Failure; Urethritis

The natural history of chlamydia is variable and may include persisting asymptomatic infection, complications, or spontaneous resolution before treatment. Reinfection is common. We evaluated whether spontaneous resolution was associated with decreased reinfection in women returning for treatment of a positive chlamydia screening test. At enrollment, participants were tested for chlamydia, treated with azithromycin, and scheduled for a 6-month follow-up visit for repeat testing. Two hundred participants returned 1 to 12 months after treatment. Spontaneous resolution at enrollment was demonstrated in 44 (22.0%). Reinfection at follow-up occurred in 33 (16.5%), being more frequent in those with persisting infection at enrollment versus spontaneous resolution (31 of 156 [19.9%] vs 2 of 44 [4.5%]; P = .016). Adjusting for age, the odds of reinfection was 4 times higher for participants with persisting infection at enrollment (odds ratio 4.0, 95% confidence interval, 1.1-25.6; P = .034). Chlamydia treatment may attenuate protective immunity in some patients.

Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Cohort Studies; Female; Follow-Up Studies; Genital Diseases, Female; Humans; Immunity; Middle Aged; Prospective Studies; Remission, Spontaneous; Risk Factors; Secondary Prevention; Young Adult

Topics: Anti-Bacterial Agents; Azithromycin; Edema; Female; Humans; IgA Vasculitis; Infant; Purpura; Remission, Spontaneous; Respiratory Tract Infections; Skin; Vasculitis, Leukocytoclastic, Cutaneous